UPC
Income statement / Annual
Last year (2023), Universe Pharmaceuticals INC's total revenue was $32.31 M,
a decrease of 19.52% from the previous year.
In 2023, Universe Pharmaceuticals INC's net income was -$6.16 M.
See Universe Pharmaceuticals INC’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
09/30/2023 |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
09/30/2018 |
| Operating Revenue |
$32.31 M
|
$40.14 M
|
$47.98 M
|
$30.70 M
|
$33.23 M
|
$28.51 M
|
| Cost of Revenue |
$22.23 M |
$18.25 M |
$22.66 M |
$16.61 M |
$19.82 M |
$15.11 M |
| Gross Profit |
$10.08 M |
$21.89 M |
$25.33 M |
$14.09 M |
$13.41 M |
$13.41 M |
| Gross Profit Ratio |
0.31 |
0.55 |
0.53 |
0.46 |
0.4 |
0.47 |
| Research and Development
Expenses |
$4.86 M
|
$7.64 M
|
$5.47 M
|
$583,125.00
|
$618,437.00
|
$789,382.00
|
| General & Administrative
Expenses |
$2.22 M
|
$1.75 M
|
$3.30 M
|
$1.24 M
|
$713,647.00
|
$704,866.00
|
| Selling & Marketing
Expenses |
$6.78 M
|
$19.08 M
|
$2.97 M
|
$1.56 M
|
$1.58 M
|
$1.68 M
|
| Selling, General &
Administrative Expenses |
$9.00 M
|
$20.84 M
|
$6.27 M
|
$2.80 M
|
$2.29 M
|
$2.39 M
|
| Other Expenses |
-$17,531.00 |
$430,307.00 |
-$80,434.00 |
$365,769.00 |
$445,774.00 |
$5,014.00 |
| Operating Expenses |
$13.84 M |
$28.91 M |
$11.74 M |
$3.74 M |
$3.36 M |
$3.65 M |
| Cost And Expenses |
$35.84 M |
$47.16 M |
$34.39 M |
$20.35 M |
$23.18 M |
$18.75 M |
| Interest Income |
$0.00 |
$0.00 |
$239,549.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$156,788.00 |
$162,400.00 |
$101,604.00 |
$123,760.00 |
$129,268.00 |
$164,922.00 |
| Depreciation &
Amortization |
$508,785.00
|
$533,949.00
|
$446,878.00
|
$410,079.00
|
$418,431.00
|
$452,733.00
|
| EBITDA |
-$3.22 M
|
-$7.33 M
|
$14.20 M
|
$10.61 M
|
$10.17 M
|
$10.11 M
|
| EBITDA Ratio |
-0.1 |
-0.16 |
0.29 |
0.35 |
0.32 |
0.36 |
| Operating Income Ratio
|
-0.11
|
-0.17
|
0.28
|
0.33
|
0.29
|
0.34
|
| Total Other
Income/Expenses Net |
-$322,800.00
|
-$545,349.00
|
$88,338.00
|
-$151,292.00
|
-$99,767.00
|
-$138,278.00
|
| Income Before Tax |
-$3.85 M |
-$7.98 M |
$13.68 M |
$10.10 M |
$9.65 M |
$9.52 M |
| Income Before Tax Ratio
|
-0.12
|
-0.2
|
0.29
|
0.33
|
0.29
|
0.33
|
| Income Tax Expense |
$2.31 M |
$752,419.00 |
$2.36 M |
$2.54 M |
$2.10 M |
$1.92 M |
| Net Income |
-$6.16 M |
-$8.74 M |
$11.32 M |
$7.56 M |
$7.55 M |
$7.60 M |
| Net Income Ratio |
-0.19 |
-0.22 |
0.24 |
0.25 |
0.23 |
0.27 |
| EPS |
-1.7 |
-2.41 |
3.12 |
2.06 |
2.05 |
0.36 |
| EPS Diluted |
-1.7 |
-2.41 |
3.12 |
2.06 |
2.05 |
0.36 |
| Weighted Average Shares
Out |
$3.63 M
|
$3.63 M
|
$3.63 M
|
$3.68 M
|
$3.68 M
|
$21.00 M
|
| Weighted Average Shares
Out Diluted |
$3.63 M
|
$3.63 M
|
$3.63 M
|
$3.68 M
|
$3.68 M
|
$21.00 M
|
| Link |
|
|
|
|
|
|
